Skip to main content
Caplight Logo









Debiopharm Innovation Fund

Debiopharm Innovation Fund

Overview

Debiopharm Innovation Fund is the corporate venture capital arm of Swiss biopharmaceutical company Debiopharm, which invests in digital health, smart data, and therapeutic companies with a focus on oncology and infectious diseases.

Year Founded

2006

AUM

$150M

Portfolio Companies

11

Investments

Debiopharm Innovation Fund investments
CompanyDateStageLead
ViewsMLApr 2026SeedCo-investor
RaidiumNov 2024SeedCo-investor
ConcrNov 2023SeedCo-investor
Altis LabsJun 2023SeedLead
Book a demo to see all investments

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Book a demo to explore sector, stage, and valuation breakdowns for this investor.

Book a demo

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Book a demo to explore yearly investment trends and funding raised over time.

Book a demo

For institutional investors. Book with your work email.

FAQ

Where is Debiopharm Innovation Fund based?

Debiopharm Innovation Fund is headquartered in Lausanne, Switzerland.

When was Debiopharm Innovation Fund founded?

Debiopharm Innovation Fund was founded in 2006.

How many portfolio companies does Debiopharm Innovation Fund have?

Debiopharm Innovation Fund has 11 portfolio companies in Caplight's dataset.

What are some companies in Debiopharm Innovation Fund's portfolio?

Recent investments visible on Caplight include ViewsML, Raidium, ViewsML, Concr, Altis Labs.

What was Debiopharm Innovation Fund's most recent investment?

Debiopharm Innovation Fund's most recent investment on Caplight was in ViewsML in 2026.

What sectors does Debiopharm Innovation Fund focus on?

Debiopharm Innovation Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.

What company stages does Debiopharm Innovation Fund focus on?

Debiopharm Innovation Fund typically invests at the Early stage.

What is Debiopharm Innovation Fund's AUM?

Debiopharm Innovation Fund's assets under management are estimated between $100.0M and $250.0M.

Firmographic Details

HeadquartersLausanne
Year Founded2006
AUM$150M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?